<unk>  is an Office of AIDS Research Advisory Council (DHHS) recommended treatment option for adults and adolescents, regardless of whether they have received HIV treatment in the past. In a study of patients that had never received HIV treatment,<unk>  was as effective as lopinavir/ritonavir at 96 weeks with a once-daily dosing. It was approved by the FDA on 21 October 2008 for people not previously treated for HIV. As with other antiretrovirals,<unk>  does not cure HIV/AIDS. It is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adults and children three years of age and older when co-administered with ritonavir, in combination with other antiretroviral agents.
Darunavir
Saquinavir
Coronavir
Fosamprenavir
Entecavir
Fostemsavir
Abacavir
Indinavir